PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104609
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104609
Biomaterials Market size was valued at US$ 48,089.1 Million in 2025, expanding at a CAGR of 7.6% from 2026 to 2033.
Biomaterials are materials of either natural or synthetic origin that have the ability to make contact with biological tissue, an implant, a body system, or any constituent part of the human body for a specific purpose - i.e., for repair, replacement, augmentation, or regeneration of any organ, organ system, tissue, or implant of the body, including bone, bone marrow, skin, a blood vessel, a tissue matrix, connective tissue, teeth, and organs. The scope of materials in the biomaterials market varies from metals and biocompatible polymers to natural biomaterials and ceramics. These include orthopedic implants, cardiovascular devices, dental care, medical and pharmaceutical devices for tissue engineering applications, wound care products, and drug delivery devices.
The biomaterials market is an evolution of new material sciences focused on enhancing bioactivity, resistance against corrosion, and achieving good osteointegration and longevity of implants. These improvements also assist surgeons in applying minimally invasive methods. According to data provided by the Global Observatory on Donation and Transplantation (GODT) for 2025, more than 172,000 transplants were carried out globally, emphasizing the increasing demand for high-end biomaterials in reconstructive and regenerative healthcare. Gradually, industry is turning away from passive substances and moving towards multiple-purpose and patient-centric biologically responsive and custom products that result in improved clinical outcomes.
Biomaterials Market- Market Dynamics
Rising Demand for Orthopedic and Age-Related Medical Implants
The continued increase in longevity and the rise of musculoskeletal (MSK) diseases is creating a growing demand for durable biomaterials that perform well within the body for prolonged durations. The growth of orthopedic reconstruction has seen extensive development in titanium alloys, bioabsorbable polymers, and even next-generation ceramics, which exhibit less wear and foster easier bone growth into the devices. Additive manufacturing and surface engineering allow the development of patient-specific implants that better fit the anatomy while accelerating patient recovery and decreasing implant lifespan. According to the WHO in 2025, with an estimated 1.71 billion patients having MSK conditions globally, chronic disease is one of the fastest-growing causes of global disability, creating a need for long-term implants that better meet patient needs.
The Global Biomaterials Market is segmented on the basis of Material, Application, End User, and Region.
Polymers capture the largest share of the global biomaterials market owing to their flexibility in terms of mechanical properties, diverse chemical and mechanical characteristics, lightweight structure, and easier manipulation techniques. These biomaterials are extensively utilized in cardiovascular devices, orthopedic implants, ophthalmic applications, wound management, drug delivery devices, and tissue engineering devices. The rise in popularity of advanced materials like biodegradable polymers, bioactive and antimicrobial coatings, and bioresorbable materials for implant devices will accelerate clinical acceptance. Metallic biomaterials maintain a dominant share as these materials offer high mechanical strength in orthopedic and spinal/dental implant applications. Ceramic materials remain the standard in bone substitute applications due to superior biocompatibility with biological systems. Growing acceptance of natural biomaterials can be observed in applications of tissue engineering and in the field of regenerative medicine. In 2025, Evonik Industries, for instance, announced it was expanding its RESOMER bioresorbable polymer product portfolio, catering to innovation within next-generation medical device development, in which polymers make up a substantial component.
Orthopedic applications hold the largest share in the global biomaterials market. These applications include joint replacements, trauma devices, spinal implants, and bone graft substitutes, as they require higher standards for mechanical strength, fatigue resistance, and biological compatibility. Patient-specific implants, porous metals for load-bearing applications, and bioactive ceramic coatings to enhance osseointegration rates of implants and improve the bone-to-implant interface result in better functioning of these devices, further aiding in the recovery of patients. Other prominent applications are cardiovascular, dental, plastic & aesthetic surgery, gastroenterology, ophthalmology, etc. In 2025, the American Joint Replacement Registry (AJRR) continued to expand its national database, already the largest and oldest collection of joint replacement registry data in the U.S., with a cumulative total of nearly 4 million hip and knee arthroplasty procedures, illustrating the sustained clinical importance of orthopedic biomaterial applications.
Biomaterials Market- Geographical Insights
Strong existing medical device manufacturing, a vast translational research base, and proven pathways for regulation mean North America is at the forefront of the ongoing biomaterials market. The U.S. is again far and away the leading place for cutting-edge implant and drug delivery devices, research and development, biomaterial coatings, regenerative medicine, and additive manufacturing, while Canada is developing its tissue engineering and biomaterials research and development partnerships. The strong integration of hospitals, research universities, and device makers drives swift translation into next-generation biomaterials. The U.S. FDA cleared over dozens of medical devices via 510(k) pathways in 2025, reinforcing the region's leadership in introducing biomaterial-enabled medical technologies into clinical practice.
The increasing medical infrastructure in the region and large population numbers have made Asia-Pacific a growing player for biomaterial supply as well as an emerging market for clinical biomaterial applications. Medical-grade materials, including polymers, are being locally manufactured as are complex implants, coatings for implants, and regenerative medicine applications. Local players continue to expand capacity for in-house production while collaborating extensively with multinationals, driven by robust and increasing surgical and interventional rates as countries invest heavily in upgrading medical facilities. The International Trade Administration (U.S. Department of Commerce) in 2025 listed Japan as one of the 15 most important medical technology markets globally, with a strong focus on areas including those using advanced biomaterials such as hip, knee, and cardiovascular implants due to aging demographic concerns.
The competitive landscape is increasingly defined by proprietary biomaterial compositions, bioactive surface technologies, manufacturing fidelity, regulatory knowledge, and capabilities for personalized healthcare not only through wide portfolios. Orthodontist magazine in the U.S. stated that major companies are investing in additive manufacturing, computational material design, antimicrobial surface treatments, and regenerative therapies-and are adding them to their product offerings to offer even better, longer-lasting patient outcomes. More integrated or vertical approach in raw material processing, implant manufacturing, and the provision of clinical data and services can provide companies better supply chain robustness and product reliability. In 2025, Zimmer Biomet announced it was serving healthcare professionals across more than 100 countries, reflecting our strategic global manufacturing footprint, expertise in regulatory affairs, and extensive portfolio of orthopedic biomaterials.
In March 2025, Evonik Expands RESOMER Biomaterials Portfolio For implantable devices, Evonik Industries launched new bioresorbable polymer materials for drug delivery or prolonged implant support.
In February 2025, Zimmer Biomet's OsseoFit Stemless Shoulder System Received U.S. FDA 510(K) clearance and innovative bio-materials that provide fixation with bone preservation for shoulder joint replacements.